Avanos Medical (NYSE:AVNS) Cut to “Hold” at Wall Street Zen

Wall Street Zen cut shares of Avanos Medical (NYSE:AVNS) from a buy rating to a hold rating in a research report released on Saturday morning.

A number of other brokerages also recently commented on AVNS. Zacks Research upgraded Avanos Medical from a “strong sell” rating to a “hold” rating in a report on Monday, January 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Avanos Medical in a report on Monday, December 22nd. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Avanos Medical has a consensus rating of “Reduce”.

Avanos Medical Stock Up 0.9%

NYSE AVNS opened at $13.82 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.15 and a quick ratio of 1.26. The stock has a market capitalization of $642.54 million, a PE ratio of -8.74 and a beta of 1.07. Avanos Medical has a 1 year low of $9.30 and a 1 year high of $15.68. The business’s 50-day moving average is $13.55 and its 200 day moving average is $12.29.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings results on Tuesday, February 24th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. Avanos Medical had a positive return on equity of 5.47% and a negative net margin of 10.40%.The business had revenue of $180.90 million during the quarter, compared to analyst estimates of $174.70 million. During the same quarter in the prior year, the company posted $0.43 EPS. Avanos Medical’s quarterly revenue was up .7% compared to the same quarter last year. Avanos Medical has set its FY 2026 guidance at 0.900-1.100 EPS. Sell-side analysts forecast that Avanos Medical will post 1.32 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Federated Hermes Inc. raised its position in shares of Avanos Medical by 2.8% in the 4th quarter. Federated Hermes Inc. now owns 25,774 shares of the company’s stock worth $289,000 after acquiring an additional 691 shares in the last quarter. Versant Capital Management Inc boosted its position in shares of Avanos Medical by 49.7% during the third quarter. Versant Capital Management Inc now owns 2,692 shares of the company’s stock valued at $31,000 after purchasing an additional 894 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Avanos Medical by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,955 shares of the company’s stock valued at $386,000 after purchasing an additional 1,121 shares in the last quarter. Azzad Asset Management Inc. ADV grew its stake in Avanos Medical by 3.0% in the third quarter. Azzad Asset Management Inc. ADV now owns 43,230 shares of the company’s stock worth $500,000 after purchasing an additional 1,240 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in Avanos Medical by 132.6% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,496 shares of the company’s stock worth $28,000 after purchasing an additional 1,423 shares during the period. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.

In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.